Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 266

1.

Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.

Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A.

BMJ. 2012 Mar 12;344:e1369. doi: 10.1136/bmj.e1369.

PMID:
22411919
[PubMed - indexed for MEDLINE]
Free Article
2.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

PMID:
20646668
[PubMed - indexed for MEDLINE]
Free Article
3.

Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis.

McIntosh B, Cameron C, Singh SR, Yu C, Ahuja T, Welton NJ, Dahl M.

Open Med. 2011;5(1):e35-48. Epub 2011 Mar 1. Review.

PMID:
22046219
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.

Scheen AJ.

Diabetes Metab. 2012 Apr;38(2):89-101. doi: 10.1016/j.diabet.2011.11.001. Epub 2011 Dec 22. Review.

PMID:
22197148
[PubMed - indexed for MEDLINE]
Free Article
5.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
6.

Head-to-head comparison of dipeptidyl peptidase-IV inhibitors and sulfonylureas - a meta-analysis from randomized clinical trials.

Zhang Y, Hong J, Chi J, Gu W, Ning G, Wang W.

Diabetes Metab Res Rev. 2014 Mar;30(3):241-56. doi: 10.1002/dmrr.2482. Review.

PMID:
24123720
[PubMed - indexed for MEDLINE]
7.

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis.

Deacon CF, Mannucci E, Ahrén B.

Diabetes Obes Metab. 2012 Aug;14(8):762-7. doi: 10.1111/j.1463-1326.2012.01603.x. Epub 2012 Apr 24. Review.

PMID:
22471248
[PubMed - indexed for MEDLINE]
8.

Choice of therapy in patients with type 2 diabetes inadequately controlled with metformin and a sulphonylurea: a systematic review and mixed-treatment comparison meta-analysis.

McIntosh B, Cameron C, Singh SR, Yu C, Dolovich L, Houlden R.

Open Med. 2012 Jun 4;6(2):e62-74. Print 2012. Review.

PMID:
23696771
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Dipeptidyl peptidase-4 inhibitors: 3 years of experience.

Derosa G, Maffioli P.

Diabetes Technol Ther. 2012 Apr;14(4):350-64. doi: 10.1089/dia.2011.0204. Epub 2012 Feb 10. Review.

PMID:
22324384
[PubMed - indexed for MEDLINE]
10.

Vildagliptin: a review of its use in type 2 diabetes mellitus.

Keating GM.

Drugs. 2010 Nov 12;70(16):2089-112. doi: 10.2165/11206370-000000000-00000. Review.

PMID:
20964454
[PubMed - indexed for MEDLINE]
11.

Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.

Kumar A.

Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:21-5. doi: 10.1002/dmrr.2350. Review.

PMID:
23280862
[PubMed - indexed for MEDLINE]
12.

Effect of antidiabetic agents added to metformin on glycaemic control, hypoglycaemia and weight change in patients with type 2 diabetes: a network meta-analysis.

Liu SC, Tu YK, Chien MN, Chien KL.

Diabetes Obes Metab. 2012 Sep;14(9):810-20. doi: 10.1111/j.1463-1326.2012.01606.x. Epub 2012 Apr 29. Review.

PMID:
22486990
[PubMed - indexed for MEDLINE]
13.

Efficacy and safety of long-acting glucagon-like peptide-1 receptor agonists compared with exenatide twice daily and sitagliptin in type 2 diabetes mellitus: a systematic review and meta-analysis.

Pinelli NR, Hurren KM.

Ann Pharmacother. 2011 Jul;45(7-8):850-60. doi: 10.1345/aph.1Q024. Epub 2011 Jul 5. Review.

PMID:
21730278
[PubMed - indexed for MEDLINE]
14.

Effect of antihyperglycemic agents added to metformin and a sulfonylurea on glycemic control and weight gain in type 2 diabetes: a network meta-analysis.

Gross JL, Kramer CK, Leitão CB, Hawkins N, Viana LV, Schaan BD, Pinto LC, Rodrigues TC, Azevedo MJ; Diabetes and Endocrinology Meta-analysis Group (DEMA).

Ann Intern Med. 2011 May 17;154(10):672-9. doi: 10.7326/0003-4819-154-10-201105170-00007. Review.

PMID:
21576535
[PubMed - indexed for MEDLINE]
15.

Differentiating among incretin therapies: a multiple-target approach to type 2 diabetes.

Cornell S.

J Clin Pharm Ther. 2012 Oct;37(5):510-24. doi: 10.1111/j.1365-2710.2012.01342.x. Epub 2012 Mar 21. Review.

PMID:
22436069
[PubMed - indexed for MEDLINE]
16.

Evaluating second-line treatment options for type 2 diabetes: focus on secondary effects of GLP-1 agonists and DPP-4 inhibitors.

Boland CL, Degeeter M, Nuzum DS, Tzefos M.

Ann Pharmacother. 2013 Apr;47(4):490-505. doi: 10.1345/aph.1R444. Epub 2013 Apr 2. Review.

PMID:
23548652
[PubMed - indexed for MEDLINE]
17.

Effects on lipid profile of dipeptidyl peptidase 4 inhibitors, pioglitazone, acarbose, and sulfonylureas: meta-analysis of placebo-controlled trials.

Monami M, Vitale V, Ambrosio ML, Bartoli N, Toffanello G, Ragghianti B, Monami F, Marchionni N, Mannucci E.

Adv Ther. 2012 Sep;29(9):736-46. doi: 10.1007/s12325-012-0045-5. Epub 2012 Aug 24. Review.

PMID:
22923161
[PubMed - indexed for MEDLINE]
18.

Sitagliptin phosphate: a DPP-4 inhibitor for the treatment of type 2 diabetes mellitus.

Zerilli T, Pyon EY.

Clin Ther. 2007 Dec;29(12):2614-34. doi: 10.1016/j.clinthera.2007.12.034. Review.

PMID:
18201579
[PubMed - indexed for MEDLINE]
19.

Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.

Penfornis A, Borot S, Raccah D.

Diabetes Metab. 2008 Feb;34 Suppl 2:S78-90. doi: 10.1016/S1262-3636(08)73399-8. Review.

PMID:
18640590
[PubMed - indexed for MEDLINE]
20.

Exenatide: an incretin mimetic for the treatment of type 2 diabetes mellitus.

Iltz JL, Baker DE, Setter SM, Keith Campbell R.

Clin Ther. 2006 May;28(5):652-65. Review.

PMID:
16861088
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk